Search results
Showing 676 to 690 of 2044 results for guidelines
Dimethyl fumarate for treating relapsing‑remitting multiple sclerosis (TA320)
Evidence-based recommendations on dimethyl fumarate (Tecfidera) for treating relapsing-remitting multiple sclerosis in adults.
Register your organisation as a stakeholder with NICE.
Evidence-based recommendations on rivaroxaban (Xarelto) for preventing venous thromboembolism after total hip or total knee replacement in adults.
View recommendations for TA170Show all sections
How voluntary and community sector (VCS) organisations can help us develop guidance
Support for organisations who contribute to developing our guidance
A quick guide for home care managers providing medicines support.
A quick guide for home care managers providing medicines support
A quick guide for practitioners supporting people growing older with learning disabilities.
In development [GID-HST10054] Expected publication date: TBC
Awaiting development [GID-TA10438] Expected publication date: TBC
Awaiting development [GID-TA10439] Expected publication date: TBC
Arranging services for people with a learning disability and behaviour that challenges
information NICE guideline: Learning disabilities and behaviour that challenges - service design and delivery . NICE...
Evidence-based recommendations on SonoVue (sulphur hexafluoride microbubbles) for contrast-enhanced ultrasound imaging of the liver
Mirabegron for treating symptoms of overactive bladder (TA290)
Evidence-based recommendations on mirabegron (Betmiga) for treating overactive bladder in adults.
Help for care home managers and staff to prevent infection